Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (491-500 of 635) with videos related to

Pageof 64
Sort By:
BJU International|March 1, 2012
Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomyPhillip M Pierorazio, Ashley E Ross, Brian M Lin, et al.
Histopathology|November 2, 2016
The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelMuhammad T Idrees, Thomas M Ulbright, Esther Oliva, et al.
European Urology|October 25, 2012
Contemporary grading for prostate cancer: implications for patient careFadi Brimo, Rodolfo Montironi, Lars Egevad, et al.
Human Pathology|October 20, 2004
Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinomaNathalie Rioux-Leclercq, Jean-Guy Delcros, Jean-Yves Bansard, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
The American Journal of Surgical Pathology|January 5, 2021
Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 CasesPedram Argani, Derrick W Q Lian, Abbas Agaimy, et al.
World Journal of Urology|February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year resultsNeal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 20, 2009
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasTamara L Lotan, Antoun Toubaji, Roula Albadine, et al.
Human Pathology|August 9, 2011
Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic centerRoula Albadine, Matthew E Hyndman, Alcides Chaux, et al.
European Urology|March 17, 2012
A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimensSamson W Fine, Mahul B Amin, Daniel M Berney, et al.
Pageof 64

Showing results (491-500 of 635) with videos related to

Sort By:
Pageof 64
BJU International|March 1, 2012
Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomyPhillip M Pierorazio, Ashley E Ross, Brian M Lin, et al.
Histopathology|November 2, 2016
The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelMuhammad T Idrees, Thomas M Ulbright, Esther Oliva, et al.
European Urology|October 25, 2012
Contemporary grading for prostate cancer: implications for patient careFadi Brimo, Rodolfo Montironi, Lars Egevad, et al.
Human Pathology|October 20, 2004
Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinomaNathalie Rioux-Leclercq, Jean-Guy Delcros, Jean-Yves Bansard, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
The American Journal of Surgical Pathology|January 5, 2021
Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 CasesPedram Argani, Derrick W Q Lian, Abbas Agaimy, et al.
World Journal of Urology|February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year resultsNeal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 20, 2009
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasTamara L Lotan, Antoun Toubaji, Roula Albadine, et al.
Human Pathology|August 9, 2011
Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic centerRoula Albadine, Matthew E Hyndman, Alcides Chaux, et al.
European Urology|March 17, 2012
A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimensSamson W Fine, Mahul B Amin, Daniel M Berney, et al.
Pageof 64